Related Experiment Video

Updated: Apr 27, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

5.7K

SIPL1 enhances the proliferation, attachment, and migration of CHO cells by inhibiting PTEN function

Jason De Melo1, Vincent Wu1, Lizhi He1

  • 1Division of Nephrology, Department of Medicine, McMaster University, Hamilton, ON L8N 4A6, Canada.

International Journal of Molecular Medicine
|July 15, 2014
PubMed

Insights

The novel PTEN-negative regulator (PTEN-NR) SIPL1 inactivates PTEN, promoting cell proliferation and migration. This study reveals SIPL1

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • PTEN (Phosphatase and tensin homolog) is a crucial tumor suppressor.
  • PTEN regulates cell proliferation, adhesion, and migration via the PI3K-AKT pathway.
  • SIPL1 is identified as a novel PTEN-negative regulator (PTEN-NR) implicated in tumorigenesis.

Purpose of the Study:

  • To investigate the role of SIPL1 in regulating PTEN function related to cell adhesion and migration.
  • To explore the mechanism by which SIPL1 affects PTEN activity and downstream signaling.

Main Methods:

  • Utilized Chinese Hamster Ovary (CHO-K1) cells for experiments.
  • Employed western blotting and qPCR analyses to assess protein and mRNA levels.
  • Microscopy techniques were used to observe cellular changes.

Main Results:

  • Overexpression of SIPL1 led to a decrease in PTEN protein levels in CHO-K1 cells.
  • PTEN downregulation by SIPL1 was not attributed to reduced PTEN mRNA or ubiquitin-dependent degradation.
  • SIPL1 overexpression enhanced AKT activation, promoting cell proliferation and increasing cell migration and attachment.

Conclusions:

  • SIPL1 promotes AKT activation by reducing PTEN protein levels in CHO-K1 cells.
  • SIPL1's mechanism involves functional inactivation of PTEN, leading to increased cell proliferation and migration.
  • These findings highlight SIPL1 as a key regulator in cellular processes relevant to cancer progression.

More Related Videos

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis07:26

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Published on: January 31, 2025

1.1K
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

12.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K